AMERICAN JOURNAL OF HEMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2015-09-21 xueling1027

审稿速度:1.0 | 投稿命中率:25.0
经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）

603 0

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2014-06-06 SamanthaS

审稿速度:1.0 | 投稿命中率:25.0
经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%

490 0

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2013-11-06 satellite119

审稿速度:1.0 | 投稿命中率:25.0
经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%.
虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。

443 0

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2013-08-22 匿名用户

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。

500 0

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2012-01-12 hbt1979

该杂志偏重临床，单纯基础研究要小心哦。

500 0

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2011-06-29 medwu

看涨哦，如果明天再升一升，有望突破3分

392 0

[GetPortalCommentsPageByObjectIdResponse(id=515482, encodeId=2d8a51548202, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：他们有一个rapid in-house review，内审非常快，投出去3天就收到拒信了，都没有送外审（泪奔）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70441612219, createdName=xueling1027, createdTime=Mon Sep 21 13:41:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503388, encodeId=cb0350338886, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：速度非常快，我6月4号投稿，6月6号回复“ our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology.We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _<%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cea103647, createdName=SamanthaS, createdTime=Fri Jun 06 23:25:00 CST 2014, time=2014-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499700, encodeId=03cb499e0084, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿速度很快，周一投的稿，周三就拒了，拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%. 虽然被拒了，感觉该杂志效率还是很高的。以后再来尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ee89508, createdName=satellite119, createdTime=Wed Nov 06 16:18:00 CST 2013, time=2013-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498567, encodeId=221c49856ec1, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天状态就变成Evaluating Recommendation，应该是副主编直接提交给主编做Decision了。审稿结果暂时还不知道，后续再补充。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 22 02:42:00 CST 2013, time=2013-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486282, encodeId=7e3248628204, content=该杂志偏重临床，单纯基础研究要小心哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbt1979, createdTime=Thu Jan 12 11:04:00 CST 2012, time=2012-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481296, encodeId=856248129657, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469643, encodeId=f94346964321, content=杂志名称：American Journal of Hematology 专业领域: 血液 杂志国家：美国 投稿日期：2008年11月22日 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh 修回日期：2008年12月09日 修改方式（大修，小修，拒稿）：大修1次 接受日期：2009年02月09日 是否收版面费：否 分享的经验或教训：该杂志审稿较快，审稿周期一般2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Hematology, createdTime=Tue Dec 15 12:20:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]

2009-12-15 Hematology

杂志名称：American Journal of Hematology
专业领域: 血液
杂志国家：美国
投稿日期：2008年11月22日
投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://mc.manuscriptcentral.com/ajh
修回日期：2008年12月09日
修改方式（大修，小修，拒稿）：大修1次
接受日期：2009年02月09日
是否收版面费：否
分享的经验或教训：该杂志审稿较快，审稿周期一般2周。

476 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务